Amylyx Pharmaceuticals, Inc. (AMLX)
12.24
+0.03
(+0.25%)
USD |
NASDAQ |
Jan 12, 09:38
Amylyx Pharmaceuticals Shareholders Equity (Quarterly): 332.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Treace Medical Concepts, Inc. | 89.19M |
| Baxter International, Inc. | 7.241B |
| Humana, Inc. | 18.52B |
| Avantor, Inc. | 5.570B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 362.74M |
| Total Liabilities (Quarterly) | 30.74M |
| Debt to Equity Ratio | 0.0179 |
| Current Ratio | 13.70 |
| Net Debt Paydown Yield | -0.04% |